Our Latest News

News


Announcement


ScreenPoint Medical Hits New Milestones

World’s Leading Breast AI Software, Transpara Surpasses 5 Million Mammograms and 1 Million Tomosynthesis Studies Analyzed to Support Radiologists Reading

Read more

Announcement


ScreenPoint Medical Showcases Global Momentum for Transpara(R) Breast AI at EUSOBI

The Most Clinically Validated Breast AI Featured in 4 Significant Peer-Reviewed Studies in Past 6 Months, Better Workflow to Increase

Read more

Media coverage


ScreenPoint and Transpara in the News!

Our Nijmegen office was visited by a Netherlands-based news crew the week of August 1. What was the big news?

Read more

Announcement


Transpara® Helps Radiologists Detect More Cancers while Safely Reducing Workload

Randomized Controlled Trial for Breast AI as Second Reader: Preliminary Results Published in The Lancet Oncology   Transpara®-assisted workflow helps

Read more

Announcement Clinical evidence


First randomised trial finds AI-supported mammography screening is safe and almost halved radiologist workload

Press Release From Lancet Oncology: The AI in use is Transpara First randomised trial finds AI-supported mammography screening is safe

Read more

Announcement


Artificial Intelligence from ScreenPoint Medical and Volpara Health Demonstrates Ability to Predict Long-Term Breast Cancer Risk

Research from Mayo Clinic and UCSF find that the combination of Transpara ® Exam Score with Volpara TruDensity® can predict

Read more
Load More